BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, June 8, 2026
See today's BioWorld
Home
» Revived bills impose DEA accountability, cut through regulatory tape
To read the full story,
subscribe
or
sign in
.
Revived bills impose DEA accountability, cut through regulatory tape
Jan. 28, 2015
By
Mari Serebrov
Enough with the inexplicable delays, lawmakers and health advocates said Tuesday as they discussed a bill that would force the Drug Enforcement Administration (DEA) to schedule new drugs in a predictable, more timely manner.
BioWorld